NVCT vs. BBAI

Last updated Apr 1, 2026

Compare and contrast key facts about Nuvectis Pharma Inc (NVCT) and BigBear.ai Holdings, Inc. (BBAI).

Performance

NVCT vs. BBAI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nuvectis Pharma Inc (NVCT) and BigBear.ai Holdings, Inc. (BBAI). The values are adjusted to include any dividend payments, if applicable.

NVCT vs. BBAI - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
NVCT Nuvectis Pharma Inc	2.38%	39.56%	-35.13%	11.20%	130.77%
BBAI BigBear.ai Holdings, Inc.	-34.81%	21.35%	107.94%	217.65%	-87.26%

Fundamentals

Market Cap NVCT : $168.61M BBAI : $12.63B
EPS NVCT : -$1.31 BBAI : -$0.20
PB Ratio NVCT : 9.16 BBAI : 20.64
Total Revenue (TTM) NVCT : $0.00 BBAI : $127.67M
Gross Profit (TTM) NVCT : $0.00 BBAI : $28.48M
EBITDA (TTM) NVCT : $0.00 BBAI : -$253.90M

Returns By Period

In the year-to-date period, NVCT achieves a 2.38% return, which is significantly higher than BBAI's -34.81% return.

NVCT

• 1D: 3.20%
• 1M: -12.75%
• YTD: 2.38%
• 6M: 28.41%
• 1Y: -20.88%
• 3Y*: -16.15%
• 5Y*: —
• 10Y*: —

BBAI

• 1D: 15.79%
• 1M: -11.11%
• YTD: -34.81%
• 6M: -46.01%
• 1Y: 23.08%
• 3Y*: 12.99%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

NVCT vs. BBAI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NVCT

NVCT Risk / Return Rank: 26
NVCT Sharpe Ratio Rank: 26
NVCT Sortino Ratio Rank: 27
NVCT Omega Ratio Rank: 28
NVCT Calmar Ratio Rank: 23
NVCT Martin Ratio Rank: 27

BBAI

BBAI Risk / Return Rank: 53
BBAI Sharpe Ratio Rank: 50
BBAI Sortino Ratio Rank: 63
BBAI Omega Ratio Rank: 55
BBAI Calmar Ratio Rank: 48
BBAI Martin Ratio Rank: 49

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NVCT vs. BBAI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nuvectis Pharma Inc (NVCT) and BigBear.ai Holdings, Inc. (BBAI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NVCT	BBAI	Difference
Sharpe ratio Return per unit of total volatility	-0.34	0.22	-0.56
Sortino ratio Return per unit of downside risk	-0.13	1.24	-1.37
Omega ratio Gain probability vs. loss probability	0.99	1.13	-0.14
Calmar ratio Return relative to maximum drawdown	-0.54	0.24	-0.78
Martin ratio Return relative to average drawdown	-0.83	0.51	-1.34
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NVCT vs. BBAI - Sharpe Ratio Comparison

The current NVCT Sharpe Ratio is -0.34, which is lower than the BBAI Sharpe Ratio of 0.22. The chart below compares the historical Sharpe Ratios of NVCT and BBAI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	NVCT	BBAI	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.34	0.22	-0.56
Sharpe Ratio (All Time) Calculated using the full available price history	0.21	-0.11	+0.32

Correlation

The correlation between NVCT and BBAI is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

NVCT vs. BBAI - Dividend Comparison

Neither NVCT nor BBAI has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

NVCT vs. BBAI - Drawdown Comparison

The maximum NVCT drawdown since its inception was -77.89%, smaller than the maximum BBAI drawdown of -95.01%. Use the drawdown chart below to compare losses from any high point for NVCT and BBAI.

Drawdown Indicators

	NVCT	BBAI	Difference
Max Drawdown Largest peak-to-trough decline	-77.89%	-95.01%	+17.12%
Max Drawdown (1Y) Largest decline over 1 year	-48.45%	-65.88%	+17.43%
Current Drawdown Current decline from peak	-62.18%	-72.26%	+10.08%
Average Drawdown Average peak-to-trough decline	-53.24%	-71.00%	+17.76%
Ulcer Index Depth and duration of drawdowns from previous peaks	31.33%	31.07%	+0.26%

Volatility

NVCT vs. BBAI - Volatility Comparison

The current volatility for Nuvectis Pharma Inc (NVCT) is 13.54%, while BigBear.ai Holdings, Inc. (BBAI) has a volatility of 22.77%. This indicates that NVCT experiences smaller price fluctuations and is considered to be less risky than BBAI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NVCT	BBAI	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.54%	22.77%	-9.23%
Volatility (6M) Calculated over the trailing 6-month period	36.63%	66.27%	-29.64%
Volatility (1Y) Calculated over the trailing 1-year period	61.94%	104.87%	-42.93%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	110.99%	178.01%	-67.02%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	110.99%	178.01%	-67.02%

Financials